Articles /

Highlights from Rayner’s Trifocal User Meeting in Seoul, South Korea

Media Mice coverage of Rayner's Trifocal User Meeting in Seoul, South Korea. Presentations on large scale data with RayOne Trifocal by Dr. Jung Wan Kim and Dr. Hyung-Goo Kwon, as well as an in-depth review of Sulcoflex Trifocal by Professor Gerd Auffarth.


Cataract patient observations two years after the pandemic and future prospects

Dr Marta Misiuk-Hojło (Poland) presents an opinion piece which explores how the pandemic has contributed to a decrease in cataract procedures performed, and that some patients are now reporting at a more advanced stage of cataract. Dr Misiuk-Hojło goes on to explore the development of new intraocular lens technologies, including…


Clinical outcomes after duet procedure for reversible trifocality

Clinical outcomes of patients who had primary lens implantation in the capsular bag and subsequently a supplementary trifocal lens implanted in the ciliary sulcus (duet procedure) to create reversible trifocality.


New IOL offers greater spectacle independence over wider range

Patients desire spectacle independence at all distances. Dr Lucio Buratto shares his early experience with a recently launched IOL suggests that it can satisfy their demands for extended depth of vision.


How to choose the right presbyopia correction solution for your patients

Dr Fernando Llovet, Prof Ramin Khoramnia, Mr Sheraz Daya, Mr Allon Barsam, Miss Masara Laginaf, Miss Purvi Thomson and Mark Vizard share their experience and results with premium cataract and refractive IOLs, as well as discuss effective management of dry eye and the collection of long term patient reported outcomes.


Leading surgeons evaluate the effectiveness of Sulcoflex Trifocal

A white paper that details a prospective multicentre evaluation assessing visual acuity and patient satisfaction in pseudophakic patients with bilaterally implanted supplementary Trifocal intraocular lens.


Rayner ESCRS Clinical Report 2019

Eye Science written report from the ESCRS congress in Paris, France.


Rayner ESCRS Clinical Report 2018

Eye Science written report from the ESCRS congress in Vienna, Austria.


Interviews /

Mr Andrew Turnbull discusses RayOne EMV in comparison to multifocal IOLs

Mr Andrew Turnbull explains the patient selection process for enhanced monofocal vs trifocal IOLs and the benefits of the RayOne EMV.


Prof Amon and Dr Wendelstein discuss Sulcoflex

Professor Michael Amon and Dr Jascha Wendelstein share their experience with Sulcoflex supplementary lenses.


Rayner ESCRS 2022 Symposium: challenges in cataract surgery and advanced technology IOLs

Professor Findl (Austria), Professor Auffarth (Germany), Mr Barsam (United Kingdom), Dr Bostanci (Turkey) and Dr Ferreira (Portugal) complete the panel of surgeons for the Rayner-sponsored satellite symposium.


Prof. Auffarth über Sulcoflex und seine kürzlich veröffentlichte Studie im AJO

Prof Auffarth berichtet über seine Erfahrung mit Sulcoflex, die Vorteile der Reversibilität dieser additiven Linse und der kürzlich erschienenen Publikation.


Dr. Holland zu seinen Erfahrungen mit Sulcoflex Trifocal und RayOne EMV

Dr. Holland berichtet über seine langjährigen Erfahrungen mit Sulcoflex Trifocal und seinen ersten Ergebnissen mit RayOne EMV auf der DOC in Nürnberg 2022.


Interview with Prof Michael Amon – inventor of the Sulcoflex platform (DE)

At the Peer2Peer surgeon evening in Vienna (Austria), we sat down with Professor Michael Amon to learn about the Sulcoflex supplementary IOL platform that he developed in collaboration with Rayner.


Learn about Sulcoflex Trifocal with Prof Michael Amon in Vienna

Hear from Prof. Michael Amon, inventor of the Sulcoflex platform, as he shares his experience and results with the Sulcoflex Trifocal supplementary IOL during the Rayner Peer2Peer surgeon evening in Vienna.


DUET Verfahren für Presbyopie, Katarakt und Pseudophakie (DE)

Vortrag von Dr. Ilya Kotomin (Smile Eyes Augen- und Laserzentrum Leipzig) beim virtuellen DGII Kongress am 27. Februar 2021.


WEBINAR | Premium IOL update plus RayPRO as a contactless telehealth solution

Webinar recording from June 2020 about introducing premium IOLs to your practice as well as the importance of capturing Patient Reported Outcomes (PROs). With Dr Khaled Al-Arfaj, Sam Carter and Professor Michael Amon.


WEBINAR | Returning to work with premium IOLs plus RayPRO

Webinar recording from May 2020 about capsular bag and supplementary trifocal IOLs, as well as the importance of capturing Patient Reported Outcomes (PROs). With Mr Allon Barsam, Professor Michael Amon and Mr Andrews Morris.


Panel discussion on trifocal technology and the Sulcoflex supplementary IOL

A panel consisting of Matteo Piovella, MD, Thomas Kohnen, MD, PhD, FEBO, Cedric Schweitzer, MD, Allon Barsam, MD, MA, FRCOphth, Ewa Mrukwa-Kominek, MD, PhD, Gonzalo Bernabéu, MD, and Michael Amon, MD, FEBO, discuss trifocal technology and the new Sulcoflex Trifocal.


Sulcoflex Trifocal: History, Technique and Preliminary Results by Prof Amon

Michael Amon, MD, FEBO, introduces the Sulcoflex Trifocal supplementary IOL and shares the outcomes from his early experience. Professor Amon also covers the surgical techniques for implanting the lens (the Sulcoflex DUET procedure) and gives a brief history on the Sulcoflex platform, with over over 10 years of success since…


Webinars /

Webinar: Katarakt Chirurgie im klinischen Alltag

Diskutieren Sie mit Dr. Stefanie Schmickler, Dr. Inez Frisch und Dr. Guilia Renieri über Aktuelles zu Patientenaufklärung bei Sonderlinsen, Ablaufoptimierung im OP und Fallbeispielen.


Podcasts /

Post cast sample – 04 – With a long title that can stretch over 3 lines

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat…


Post cast sample – 01 : With a long title that can stretch over 3 lines

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Est sit amet facilisis magna etiam tempor. Nisl nunc mi ipsum faucibus vitae aliquet nec ullamcorper sit. Lobortis scelerisque fermentum dui faucibus in ornare quam. Mattis vulputate enim nulla aliquet porttitor…


Contact us /

This field is for validation purposes and should be left unchanged.